Rare agouti thoracic tumor reclassified as histiocytic sarcoma: full analysis

A newly published brief report in the Journal of Veterinary Diagnostic Investigation adds a rare diagnosis to the exotic animal pathology literature: pulmonary histiocytic sarcoma with cranial mediastinal involvement in a Brazilian red-rumped agouti. The paper, posted online May 11, 2026, states that histiocytic sarcoma had not previously been reported in this species, making the case notable both for its rarity and for the diagnostic confusion it created at necropsy. (journals.sagepub.com)

What made the case especially challenging was where the mass was found and how it looked. According to the report, the primary differential diagnosis based on location and gross appearance was chemodectoma, a reasonable starting point for a cranial mediastinal mass that resembled a neuroendocrine tumor. That initial impression changed only after histologic review and immunohistochemical workup showed a profile consistent with histiocytic sarcoma rather than a neuroendocrine or endothelial neoplasm. (journals.sagepub.com)

The authors report variable immunoreactivity for IBA1, CD204, MHC II, and CD163, with no immunolabeling by neuroendocrine and endothelial cell markers. In practical terms, that meant the lesion’s gross morphology was not enough to establish lineage, and the diagnosis depended on a comparative pathology approach using a broader marker panel. The report frames that as a central lesson of the case: in exotic species with limited baseline tumor data, thoracic neoplasms may require more extensive immunophenotyping than clinicians or diagnosticians might expect from better-characterized domestic species. (journals.sagepub.com)

The broader literature supports that caution. UC Davis describes histiocytic sarcoma as a malignant neoplasm of dendritic cell or macrophage lineage that may present as localized or disseminated disease, and notes that pulmonary histiocytic sarcoma has historically been mistaken for other lung tumors before lineage-specific markers became more widely used. VIN educational material similarly notes that histiocytic sarcoma can arise in the lung and other sites, and that its presentation can overlap with other sarcomas and poorly differentiated tumors. (histiocytosis.ucdavis.edu)

Although direct expert reaction to this agouti report was not readily available at the time of writing, related wildlife and exotic-animal case literature suggests why this paper will likely get attention from veterinary diagnosticians. Recent reports have documented histiocytic sarcoma in species such as collared peccaries, civets, degus, ferrets, rabbits, chinchillas, and capybaras, but these remain isolated case reports rather than a mature evidence base. That makes each well-characterized case useful for refining differentials, validating marker panels, and building species-spanning reference points for pathology services that may only see one such case in years. (link.springer.com)

Why it matters: For veterinarians, the immediate takeaway isn’t that agoutis are emerging as an oncology category. It’s that uncommon species can still develop familiar malignancies in unfamiliar anatomic patterns, and those cases can be easy to misclassify if diagnostics stop at imaging or gross pathology. For clinicians managing zoo, wildlife, research, or mixed exotic caseloads, the report reinforces the value of submitting thoracic masses for full histopathology and immunohistochemistry, particularly when a lesion’s location seems to point strongly toward a more common diagnosis. For pathologists, it also highlights the ongoing need to interpret immunolabeling cautiously across species, where marker performance may be variable and validation data limited. (journals.sagepub.com)

There’s also a comparative medicine angle. The references cited in the paper and the surrounding literature show histiocytic sarcoma appearing across a wide range of mammals, often with overlapping morphologic features but inconsistent organ distribution and immunophenotypes. That kind of cross-species pattern recognition can improve diagnostic accuracy not just for exotic companion animals, but also for zoological collections and research settings where published baselines are thin. (journals.sagepub.com)

What to watch: The next step will likely be more incremental than dramatic: additional case reports, retrospective pathology reviews, and refinement of immunohistochemical panels for exotic species. If more thoracic or mediastinal masses in neotropical rodents are worked up with broader marker sets, veterinary diagnosticians may learn that some lesions previously called neuroendocrine, undifferentiated, or unclassifiable actually belong in the histiocytic sarcoma bucket. That’s an inference based on the diagnostic ambiguity described in this paper and the broader literature on histiocytic sarcoma mimics. (journals.sagepub.com)